Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Johnson

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Journal of Clinical and Translational Science|September 22, 2025
Community engagement strategies improve recruitment and enrollment in a pragmatic clinical trialKari G Vance, Jonah Pedelty, Barbara J Van Gorp, et al.
Cell Host & Microbe|November 17, 2007
A plasmid-based reverse genetics system for animal double-stranded RNA virusesTakeshi Kobayashi, Annukka A R Antar, Karl W Boehme, et al.
Diagnostic Microbiology and Infectious Disease|May 7, 2011
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteriaMichael A Pfaller, David Andes, Maiken C Arendrup, et al.
The New England Journal of Medicine|October 4, 2018
A Candida auris Outbreak and Its Control in an Intensive Care SettingDavid W Eyre, Anna E Sheppard, Hilary Madder, et al.
Nature Reviews. Microbiology|June 25, 2024
The pathobiology of human fungal infectionsGordon D Brown, Elizabeth R Ballou, Steven Bates, et al.
Nature Microbiology|April 26, 2022
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environmentJohanna Rhodes, Alireza Abdolrasouli, Katie Dunne, et al.
Nature Microbiology|October 6, 2022
Publisher Correction: Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environmentJohanna Rhodes, Alireza Abdolrasouli, Katie Dunne, et al.
JAMA Network Open|March 27, 2026
Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical TrialDana L Dailey, Carol G T Vance, Barbara J Van Gorp, et al.
Microbial Cell (Graz, Austria)|July 12, 2018
Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilmsPatrick Van Dijck, Jelmer Sjollema, Bruno P Cammue, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2026
Reply to Chen et al., "Methodological considerations for the establishment of epidemiological cutoff values for <i>Sporothrix</i> species using CLSI broth microdilution"Amanda R Dos Santos, Alexandro Bonifaz, Amanda Bombassaro, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical and Translational Science|September 22, 2025
Community engagement strategies improve recruitment and enrollment in a pragmatic clinical trialKari G Vance, Jonah Pedelty, Barbara J Van Gorp, et al.
Cell Host & Microbe|November 17, 2007
A plasmid-based reverse genetics system for animal double-stranded RNA virusesTakeshi Kobayashi, Annukka A R Antar, Karl W Boehme, et al.
Diagnostic Microbiology and Infectious Disease|May 7, 2011
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteriaMichael A Pfaller, David Andes, Maiken C Arendrup, et al.
The New England Journal of Medicine|October 4, 2018
A Candida auris Outbreak and Its Control in an Intensive Care SettingDavid W Eyre, Anna E Sheppard, Hilary Madder, et al.
Nature Reviews. Microbiology|June 25, 2024
The pathobiology of human fungal infectionsGordon D Brown, Elizabeth R Ballou, Steven Bates, et al.
Nature Microbiology|April 26, 2022
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environmentJohanna Rhodes, Alireza Abdolrasouli, Katie Dunne, et al.
Nature Microbiology|October 6, 2022
Publisher Correction: Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environmentJohanna Rhodes, Alireza Abdolrasouli, Katie Dunne, et al.
JAMA Network Open|March 27, 2026
Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical TrialDana L Dailey, Carol G T Vance, Barbara J Van Gorp, et al.
Microbial Cell (Graz, Austria)|July 12, 2018
Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilmsPatrick Van Dijck, Jelmer Sjollema, Bruno P Cammue, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2026
Reply to Chen et al., "Methodological considerations for the establishment of epidemiological cutoff values for <i>Sporothrix</i> species using CLSI broth microdilution"Amanda R Dos Santos, Alexandro Bonifaz, Amanda Bombassaro, et al.
Pageof 14